

Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 0.5 mg/pen
Amount: 1 Pre-filled Pen
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Novo Nordisk
Please log in to write Wegovy 0.5 mg review.
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 2.4 mg/pen
Amount: 1 Pre-filled Pen
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Novo Nordisk
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 10 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: 5–7 days
Average Dose: 0.25–2.0 mg/week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: None
Androgenic Rate: None
Manufacturer: Stealth Labs
Laboratory Test: View Result
Shipped Without Label!
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 0.25 mg/pen
Amount: 1 Pre-filled Pen
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Novo Nordisk
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 1.7 mg/pen
Amount: 1 Pre-filled Pen
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Novo Nordisk
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 5 mg/vial
Amount: 2 mL Vial
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Kalpa Pharmaceuticals